This Week in Startups

Why this longevity startup raised in Japan, not Silicon Valley | TWiST Tokyo | E2315

Share this episode
Anyone with this link can open it.
Share Link
Start at 0:00

This episode isn’t summarized yet

Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.

Show notes

This Week In Startups is made possible by:
Sentry https://sentry.io/twist
Agree https://agree.com
Northwest Registered Agent https://northwestregisteredagent.com/twist

Today's show:
French ex-martial artist Bilal Kharouni is building his longevity startup from Okinawa, one of the world's "blue zones." (These are regions with the most people living long, healthy lives.) In this TWiST taping from Founder University in Tokyo, Jason investigates why a $200K raise in Japan can out-build a $2M raise in San Francisco, and why the best moat for biological AI isn't the model; it's the data no one else has.
Plus a tactical and practical discussion of product market fit, why Ekei killed a growing side business to maintain focus, Japan's fast-track for regenerative medicine, and hitting the upper limits for consumer longevity gadgets. Plus a live Q&A with Founder U attendees.
Guest
Bilal Kharouni on LinkedIn: https://www.linkedin.com/in/bilal-kharouni/
Ekei Labs: https://www.ekeilabs.com/
Relevant Links
Okinawa Institute of Science and Tech (OIST): ****https://www.oist.jp/
Life Biosciences: https://www.lifebiosciences.com/
NewLimit: https://www.newlimit.com/
Centivax: https://www.centivax.com/
Medical Daily: "First Human Trial to Reverse Aging Gets FDA Clearance": https://www.medicaldaily.com/first-human-trial-reverse-aging-just-got-fda-clearance-what-epigenetic-reprogramming-actually-476076
Tim Friede snake venom article from Science: https://www.science.org/content/article/he-injected-himself-venom-decades-can-his-antibodies-help-snakebite-victims
Micro1: https://www.micro1.ai/
Whoop: https://www.whoop.com/
Station F Paris startup campus: https://stationf.co/
Japan Times: "PM Takaichi sleeps only 2-4 hours a night": https://www.japantimes.co.jp/news/2025/11/14/japan/politics/takaichi-sleep-overwork/
FDLI: "Japan's Regenerative Medicine Regulatory Pathways": https://www.fdli.org/2019/02/global-focus-japans-regenerative-medicine-regulatory-pathways-encouraging-innovation-and-patient-access/
FDA: "Right to Try": https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/right-try
STAT News: "Are Blue Zones Real?": https://www.statnews.com/2026/05/04/are-blue-zones-real-new-scrutiny-longevity-hot-spots/
Timestamps: 0:00 Founder University is back in Japan!
4:05 What Ekei Labs does
5:13 Why Japan is a longevity hub
8:52 The AI biological moat
10:05 Sentry - Your team should be focused on shipping features — not chasing down bugs. New users can get $240 in free credits when they go to https://sentry.io/twist and use the code TWIST
15:58 Right to try and the ethics of experimental therapies
22:30 Agree.com - Stop chasing invoices and automate your entire contract-to-cash stack. Go to https://agree.com and tell them Jason sent you to get 50% off for life!
24:49 Japan's fast-track regenerative medicine law
26:03 Raising in Japan vs. the US
31:32 Northwest Registered Agent - Get more when you start your business with Northwest. In 10 clicks and 10 minutes, you can form your company and walk away with a real business identity — Learn more at https://northwestregisteredagent.com/twist
40:44 Why Ekei killed a profitable service to focus
47:11 Have Blue Zones been debunked?
48:56 How socialization may extend lifespan
51:07 Founder Q&A: Booked vs. forecast revenue
55:42 Amazon's "bar raiser" framework
1:03:31 Social robots and loneliness
1:04:29 Jason on health and hustle culture

Subscribe to the TWiST500 newsletter: https://ticker.thisweekinstartups.com
Check out the TWIST500: https://www.twist500.com
Subscribe to This Week in Startups on Apple: https://rb.gy/v19fcp

Follow Lon:
X: https://x.com/lons

Follow Alex:
X: https://x.com/alex
LinkedIn: ⁠https://www.linkedin.com/in/alexwilhelm

Follow Jason:
X: https://twitter.com/Jason
LinkedIn: https://www.linkedin.com/in/jasoncalacanis

Check out all our partner offers: https://partners.launch.co/

Great TWIST interviews: Will Guidara, Eoghan McCabe, Steve Huffman, Brian Chesky, Bob Moesta, Aaron Levie, Sophia Amoruso, Reid Hoffman, Frank Slootman, Billy McFarland

Check out Jason's suite of newsletters: https://substack.com/@calacanis

Follow TWiST:
Twitter: https://twitter.com/TWiStartups
YouTube: https://www.youtube.com/thisweekin
Instagram: https://www.instagram.com/thisweekinstartups
TikTok: https://www.tiktok.com/@thisweekinstartups
Substack: https://twistartups.substack.com

Couldn't load the audio. A blocker may be stopping the show's tracking links. Open the file